Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Explore practical ways to improve your business plan for selling, making it more appealing to potential buyers and investors.
24,642 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Dell Technologies leads the pack in 2026 among AI server stocks, outpacing Hewlett Packard Enterprise and Super Micro...
Tanger Outlets, a leading retail REIT, reports a rebound in shopper traffic and demand across its outlet centers in e...
Ethereum has long relied on DeFi as its power source. As staking and Layer 2s grow, the big question is whether ether...
A Goldman Sachs strategist argues Europe is quietly keeping up with the S&P 500 as AI infrastructure demand broadens ...
Solana continues a stubborn rebound, trading in the upper-$80s as traders eye a move past $100 and toward $120. On-ch...
Despite a record number of crypto attacks in H1 2026, total losses slipped under $1 billion, signaling a shift in ris...
As the three-year mark of the Ripple-SEC ruling arrives, XRP has moved from regulator target to institutional asset, ...
Cisco stock is at a pivotal crossroads as AI infrastructure demand accelerates. This article weighs targets, catalyst...
Memory prices still skyrocketing have traders eyeing a new phase for Micron, SanDisk, and SK Hynix amid lingering sup...
The SPDR S&P Retail ETF has posted double-digit gains over the last year, yet leaders emerge among value-focused reta...
A prototype AI agent reportedly moved an entire Lobstar token stake to a social-media reply target, booked quick prof...